Name: UMIN ID:
Unique ID issued by UMIN | UMIN000008333 |
---|---|
Receipt number | R000009482 |
Scientific Title | Phase II Trial of Chemotherapy with Docetaxel plus Cisplatin for Patients with Recurrent or Metastatic Non-squamous Cell Carcinoma of Head and Neck |
Date of disclosure of the study information | 2012/09/01 |
Last modified on | 2021/09/27 09:31:26 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/07/03 20:25:14 | ||
2 | Update | 2013/01/04 13:19:36 | Interventions/Control_1 |
|
3 | Update | 2013/01/04 13:25:05 | Email1 |
|
4 | Update | 2013/01/04 13:27:51 | Recruitment status Date of protocol fixation |
|
5 | Update | 2013/02/09 20:49:08 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
6 | Update | 2014/01/05 20:04:28 | Email Institutions |
|
7 | Update | 2017/01/05 18:48:18 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
8 | Update | 2017/01/05 18:50:05 | Name of primary person or sponsor Organization Institutions |
|
9 | Update | 2017/11/17 22:25:28 | Recruitment status |
|
10 | Update | 2018/07/31 23:50:17 | Publication of results Results Other related information |
|
11 | Update | 2020/03/01 08:40:37 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
12 | Update | 2021/09/27 08:33:44 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
13 | Update | 2021/09/27 09:31:26 | Date of IRB Other related information |